MBIO
MBIO
NASDAQ · Biotechnology

Mustang Bio Inc

$0.46
+0.04 (+8.58%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,124.4% upside
Low Target $6.34
Average Target $10.33
High Target $12.82
Current Price $0.46
Current
$0.46
Target
$10.33
$6.34 $10.33 avg $12.82
Scenario Analysis
Bear Case
$6.34
1,265.2%
Low target
Base Case
$10.33
+2,124.4%
Avg target
Bull Case
$12.82
+2,660.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$1.43
-67.5% from high
52-Week Low
$0.35
+32.6% from low
Target vs 52W High
$10.33
+622.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%